CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-11 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option | +153,600 | 153,600 | ||
| 2019-11-19 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 329,145 | ||
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.12 | $47K | 0 |
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +11,485 | 329,145 | ||
| 2019-03-01 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +69,700 | 69,700 | ||
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.25 | $49K | 0 |
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 340,630 | ||
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.05 | $46K | 0 |
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 352,115 |
Page 1 of 1 · 13 trades